Skip to main content

Advertisement

Table 7 Adherence and cost (in US$ (2005)) for most recent treatment

From: Access to artemisinin combination therapy for malaria in remote areas of Cambodia

Regime (Recommended duration) % achieving recommended durations (n) Median cost in US$ (range)
Artesunate + Mefloquine (3 days) 77% (34/44) 0.77 (0 – 12.82)
Artemisinin derivative + other antimalarial (7 days) 13% (4/31) 1.67 (0.22 – 38.90)
Artemisinin alone* (7 days) 28% (8/29) 2.05 (0.38 – 26.70)
Quinine + tetracycline (+/- other antimalarial) (7 days) 0% (0/13) 1.11 (0.35 – 17.3)
Quinine (+/- other antimalarial) (7 days) 13% (3/24) 0.66 (0 – 11.10)
Chloroquine (+/- other antimalarial) (3 days) 35% (22/63) 0.67 (0.11–11.11)
Unknown - 3.59 (0 – 41.03)
  1. * Based on studies of artesunate monotherapy [41-43].